NASDAQ:ABEO

Abeona Therapeutics Stock Insider Trading

etoro logo Buy ABEO
*Your capital is at risk
$6.42
-0.0500 (-0.773%)
At Close: Jul 31, 2026

Abeona Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -84.96. In total, the insiders bought 1.05M and sold 1.29M ABEO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-84.96
Buy 1.05M shares
Sell 1.29M shares
18% Buy Activity
Negligible or No Correlation
Sell Signal High Confidence
Jul 09, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -84.96.
  • Confidence increased due to high data reliability score of 100.
  • Supported by overwhelming sell-side pressure (18% buys).

Historical Insider Trades

Date Type Person Role Amount
Feb 02, 2026
Sell
Common Stock
S-Sale
Silverstein Christine Berni
Director
Director 20 070
Value: $102.2K
Feb 02, 2026
Sell
Common Stock
S-Sale
Alland Leila
Director
Director 18 065
Value: $92.0K
Feb 02, 2026
Sell
Common Stock
S-Sale
Wuchterl Donald A.
Director
Director 14 814
Value: $75.4K
Feb 02, 2026
Sell
Common Stock
S-Sale
Crombez Eric
Director
Director 16 284
Value: $82.9K
Feb 02, 2026
Sell
Common Stock
S-Sale
Alvino Mark
Director
Director 2 000
Value: $10.2K
Jan 26, 2026
Buy
Common Stock
A-Award
Alland Leila
Director
Director 37 313
Value: $193.7K
Jan 26, 2026
Buy
Common Stock
A-Award
Alvino Mark
Director
Director 37 313
Value: $193.7K
Jan 26, 2026
Buy
Common Stock
A-Award
Crombez Eric
Director
Director 37 313
Value: $193.7K
Jan 26, 2026
Buy
Common Stock
A-Award
Wuchterl Donald A.
Director
Director 37 313
Value: $193.7K
Jan 26, 2026
Buy
Common Stock
A-Award
Zeiher Bernhardt G
Director
Director 37 313
Value: $193.7K
Jan 26, 2026
Buy
Common Stock
A-Award
Silverstein Christine Berni
Director
Director 37 313
Value: $193.7K
Jan 26, 2026
Buy
Common Stock
A-Award
Amoroso Michael
Director
Director 37 313
Value: $193.7K
Jan 26, 2026
Buy
Common Stock
A-Award
Charles Faith L.
Director
Director 37 313
Value: $193.7K
Jan 22, 2026
Sell
Common Stock
S-Sale
Vasanthavada Madhav
Chief Commercial Officer
Officer 12 610
Value: $66.7K
Jan 22, 2026
Sell
Common Stock
S-Sale
O'malley Brendan M.
SVP, Chief Legal Officer
Officer 13 578
Value: $72.4K
Jan 22, 2026
Sell
Common Stock
S-Sale
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 18 666
Value: $99.5K
Jan 22, 2026
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 69 832
Value: $372.3K
Jan 21, 2026
Sell
Common Stock
S-Sale
Alvino Mark
Director
Director 13 500
Value: $70.6K
Jan 20, 2026
Buy
Common Stock
A-Award
Vasanthavada Madhav
Chief Commercial Officer
Officer 76 621
Value: $406.9K
Jan 20, 2026
Buy
Common Stock
A-Award
Vazzano Joseph Walter
Chief Financial Officer
C-Suite Officer 133 595
Value: $709.4K
Jan 20, 2026
Buy
Common Stock
A-Award
Seshadri Vishwas
Chief Executive Officer
CEO / President 365 422
Value: $1.94M
Jan 20, 2026
Buy
Common Stock
A-Award
O'malley Brendan M.
SVP, Chief Legal Officer
Officer 113 949
Value: $605.1K
Jan 01, 2026
Buy
Employee Stock Option (right to buy)
Vasanthavada Madhav
Chief Commercial Officer
Officer 2 400
Value: $10K
Jan 01, 2026
Buy
Common Stock
Vasanthavada Madhav
Chief Commercial Officer
Officer 0
Value: $0
Dec 29, 2025
Sell
Common Stock
S-Sale
Seshadri Vishwas
Chief Executive Officer
CEO / President 25 000
Value: $132.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ABEONA THERAPEUTICS INC.
Abeona Therapeutics
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE